Who owns Structure Therapeutics Inc., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
FMR LLC: 13.2% · 28,197,369 shares — Abigail P. Johnson: 13.2% · 28,197,369 shares
BIOTECHNOLOGY VALUE FUND L P: 2.6% · 5,583,855 shares — BVF I GP LLC: 2.6% · 5,583,855 shares — BIOTECHNOLOGY VALUE FUND II LP: 1.9% · 4,053,954 shares
5 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of Structure Therapeutics Inc..
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Structure Therapeutics Inc. they hold. Together these 258 managers report 36.63% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| FMR LLC | $419M | 7,810,306 | 0.02% | 3.65% | June 30, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | $396M | 7,379,433 | 0.07% | 3.45% | June 30, 2026 |
256 more institutional holders behind a free account
See every manager reporting Structure Therapeutics Inc., how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 150 funds hold 7.59% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| Fidelity Advisor Growth Opportunities Fund | $46.2M | 0.16% | 0.34% | February 28, 2026 |
| Heritage Fund | $40.1M | 0.75% | 0.45% | April 30, 2026 |
148 more funds behind a free account
See every fund holding Structure Therapeutics Inc. and what share of its net assets the position represents.
Sign up freeLoading...
